GUANFACINE

GUANFACINE was reported 8070 times

These side effects are most commonly reported by patients taking GUANFACINE:

# Side effect Count
0 DRUG INEFFECTIVE 846
1 OFF LABEL USE 643
2 SOMNOLENCE 479
3 AGGRESSION 399
4 FATIGUE 364
5 HYPOTENSION 303
6 DIZZINESS 297
7 INSOMNIA 297
8 HEADACHE 289
9 ANXIETY 280
10 INTENTIONAL OVERDOSE 275
11 BRADYCARDIA 272
12 SUICIDAL IDEATION 271
13 NAUSEA 268
14 TOXICITY TO VARIOUS AGENTS 244
15 ELECTROCARDIOGRAM QT PROLONGED 235
16 VOMITING 235
17 ABNORMAL BEHAVIOUR 229
18 WEIGHT INCREASED 214
19 PRODUCT QUALITY ISSUE 210
20 NO ADVERSE EVENT 208
21 AGITATION 207
22 CONDITION AGGRAVATED 201
23 DRUG INTERACTION 193
24 DECREASED APPETITE 190
25 PRODUCT USE ISSUE 184
26 DEPRESSION 180
27 IRRITABILITY 178
28 PRODUCT DOSE OMISSION ISSUE 178
29 PRODUCT SUBSTITUTION ISSUE 178
30 OVERDOSE 176
31 SYNCOPE 176
32 SEIZURE 167
33 ANGER 155
34 DISTURBANCE IN ATTENTION 147
35 PRODUCT USE IN UNAPPROVED INDICATION 147
36 PSYCHOMOTOR HYPERACTIVITY 145
37 DIARRHOEA 141
38 BLOOD PRESSURE DECREASED 138
39 HYPERTENSION 138
40 RASH 138
41 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 137
42 CONSTIPATION 127
43 MALAISE 126
44 FEELING ABNORMAL 124
45 SUICIDE ATTEMPT 123
46 WEIGHT DECREASED 122
47 LETHARGY 119
48 FALL 115
49 LOSS OF CONSCIOUSNESS 114
50 TIC 114
51 DYSPNOEA 108
52 TACHYCARDIA 106
53 HYPERHIDROSIS 105
54 TREATMENT FAILURE 105
55 ABDOMINAL PAIN UPPER 102
56 SEDATION 102
57 INTENTIONAL SELF-INJURY 100
58 HALLUCINATION 98
59 PRURITUS 98
60 DRUG DOSE OMISSION 96
61 PAIN 96
62 ASTHENIA 95
63 INCORRECT DOSE ADMINISTERED 93
64 ABDOMINAL PAIN 87
65 PYREXIA 87
66 BLOOD PRESSURE INCREASED 83
67 TREMOR 83
68 COMPLETED SUICIDE 80
69 IMPULSIVE BEHAVIOUR 79
70 WRONG TECHNIQUE IN DRUG USAGE PROCESS 79
71 COUGH 78
72 EMOTIONAL DISORDER 78
73 PNEUMONIA 74
74 SLEEP DISORDER 74
75 CHEST PAIN 73
76 DEPRESSED MOOD 72
77 GYNAECOMASTIA 72
78 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 72
79 SINUS BRADYCARDIA 72
80 HOSPITALISATION 71
81 INJECTION SITE PAIN 71
82 WITHDRAWAL SYNDROME 71
83 RESTLESSNESS 69
84 PALPITATIONS 67
85 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 66
86 PAIN IN EXTREMITY 65
87 ARRHYTHMIA 62
88 DEPRESSED LEVEL OF CONSCIOUSNESS 62
89 HYPERSENSITIVITY 62
90 MOOD SWINGS 62
91 NASOPHARYNGITIS 61
92 SEROTONIN SYNDROME 61
93 ARTHRALGIA 60
94 DEHYDRATION 60
95 DISTURBANCE IN SOCIAL BEHAVIOUR 59
96 HEART RATE INCREASED 59
97 ABDOMINAL DISCOMFORT 58
98 INFLUENZA 58
99 MENTAL DISORDER 58
100 BEHAVIOUR DISORDER 57
101 CRYING 56
102 DRUG INTOLERANCE 56
103 DYSTONIA 56
104 GASTROINTESTINAL DISORDER 56
105 PARAESTHESIA 56
106 COVID-19 55
107 DEATH 55
108 DRUG EFFECT DECREASED 55
109 DRY MOUTH 55
110 URTICARIA 54
111 AUTISM SPECTRUM DISORDER 53
112 DRUG ADMINISTRATION ERROR 52
113 DRUG PRESCRIBING ERROR 52
114 ILLNESS 52
115 MOOD ALTERED 52
116 COMA 51
117 HEART RATE DECREASED 51
118 ACCIDENTAL OVERDOSE 50
119 CONVULSION 50
120 DYSARTHRIA 50
121 PSYCHOTIC DISORDER 50
122 APPLICATION SITE ERYTHEMA 49
123 MUSCLE SPASMS 49
124 EMOTIONAL DISTRESS 48
125 INCREASED APPETITE 48
126 PRODUCT AVAILABILITY ISSUE 48
127 DRUG DOSE OMISSION BY DEVICE 47
128 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 46
129 GAIT DISTURBANCE 46
130 INCORRECT DRUG ADMINISTRATION DURATION 46
131 MANIA 46
132 TREATMENT NONCOMPLIANCE 46
133 ADVERSE DRUG REACTION 45
134 DRUG HYPERSENSITIVITY 45
135 DYSKINESIA 45
136 MIGRAINE 45
137 ADVERSE EVENT 44
138 ASTHMA 44
139 SINUSITIS 44
140 CARDIAC ARREST 43
141 CONFUSIONAL STATE 43
142 HALLUCINATION, VISUAL 43
143 INTENTIONAL PRODUCT USE ISSUE 43
144 ORTHOSTATIC HYPOTENSION 43
145 VISION BLURRED 43
146 ATTENTION DEFICIT HYPERACTIVITY DISORDER 42
147 FLUSHING 42
148 PALLOR 42
149 BACK PAIN 41
150 COGNITIVE DISORDER 40
151 DRY SKIN 40
152 ERYTHEMA 40
153 INTENTIONAL PRODUCT MISUSE 40
154 PERIPHERAL SWELLING 40
155 AFFECT LABILITY 39
156 EPILEPSY 39
157 HALLUCINATION, AUDITORY 39
158 PRESYNCOPE 39
159 DERMATITIS ATOPIC 38
160 DEVICE ISSUE 38
161 HYPERSOMNIA 38
162 PRESCRIBED OVERDOSE 38
163 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 37
164 EDUCATIONAL PROBLEM 37
165 ENURESIS 37
166 BLOOD GLUCOSE INCREASED 36
167 PRODUCT ADHESION ISSUE 36
168 ACUTE KIDNEY INJURY 35
169 ALTERED STATE OF CONSCIOUSNESS 35
170 DISCOMFORT 35
171 DYSPHAGIA 35
172 PULMONARY OEDEMA 35
173 RENAL FAILURE 35
174 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 35
175 URINARY TRACT INFECTION 35
176 NIGHTMARE 34
177 OROPHARYNGEAL PAIN 34
178 THERAPY CESSATION 34
179 AFFECTIVE DISORDER 33
180 DEVICE BREAKAGE 33
181 EPISTAXIS 33
182 HYPOAESTHESIA 33
183 MUSCLE TWITCHING 33
184 OBSESSIVE-COMPULSIVE DISORDER 33
185 PRODUCT DOSE OMISSION 33
186 UNEVALUABLE EVENT 33
187 URINARY RETENTION 33
188 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 32
189 ECZEMA 32
190 INTENTIONAL DOSE OMISSION 32
191 MEMORY IMPAIRMENT 32
192 MIDDLE INSOMNIA 32
193 PRODUCT DISPENSING ERROR 32
194 THERAPEUTIC RESPONSE DECREASED 32
195 ABDOMINAL DISTENSION 31
196 CHRONIC KIDNEY DISEASE 31
197 DRUG DEPENDENCE 31
198 UNRESPONSIVE TO STIMULI 31
199 GENERALISED TONIC-CLONIC SEIZURE 30
200 HOMICIDAL IDEATION 30
201 THERAPEUTIC RESPONSE UNEXPECTED 30
202 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 29
203 DEVICE LEAKAGE 29
204 DIZZINESS POSTURAL 29
205 INFECTION 29
206 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 29
207 NASAL CONGESTION 29
208 NEUROLEPTIC MALIGNANT SYNDROME 29
209 PANIC ATTACK 29
210 PRODUCT ADMINISTRATION INTERRUPTED 29
211 BLOOD CREATINE PHOSPHOKINASE INCREASED 28
212 BRADYPNOEA 28
213 CHEST DISCOMFORT 28
214 DELIRIUM 28
215 MENTAL IMPAIRMENT 28
216 OEDEMA PERIPHERAL 28
217 PRODUCT PHYSICAL ISSUE 28
218 SCREAMING 28
219 SPEECH DISORDER 28
220 STRESS 28
221 THERAPY NON-RESPONDER 28
222 URINARY INCONTINENCE 28
223 AMNESIA 27
224 BIPOLAR DISORDER 27
225 FEELING HOT 27
226 GENERAL PHYSICAL HEALTH DETERIORATION 27
227 INITIAL INSOMNIA 27
228 THERAPEUTIC PRODUCT EFFECT DECREASED 27
229 THIRST 27
230 CONTUSION 26
231 FEAR 26
232 ACNE 25
233 GASTROINTESTINAL HAEMORRHAGE 25
234 GASTROOESOPHAGEAL REFLUX DISEASE 25
235 INABILITY TO AFFORD MEDICATION 25
236 MUSCULAR WEAKNESS 25
237 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 25
238 AKATHISIA 24
239 BRONCHITIS 24
240 CATATONIA 24
241 CHILLS 24
242 DRUG DOSE TITRATION NOT PERFORMED 24
243 EAR INFECTION 24
244 MEDICATION ERROR 24
245 OPPOSITIONAL DEFIANT DISORDER 24
246 PARANOIA 24
247 RESPIRATORY DEPRESSION 24
248 TARDIVE DYSKINESIA 24
249 THERAPY CHANGE 24
250 THERAPY PARTIAL RESPONDER 24
251 UNDERDOSE 24
252 VISUAL IMPAIRMENT 24
253 ALOPECIA 23
254 CROHN^S DISEASE 23
255 DELUSION 23
256 ENCEPHALOPATHY 23
257 FRUSTRATION TOLERANCE DECREASED 23
258 MOVEMENT DISORDER 23
259 SELF-DESTRUCTIVE BEHAVIOUR 23
260 SELF-INJURIOUS IDEATION 23
261 THERAPEUTIC RESPONSE SHORTENED 23
262 THERAPY INTERRUPTED 23
263 WHITE BLOOD CELL COUNT DECREASED 23
264 ACCIDENTAL EXPOSURE TO PRODUCT 22
265 APPLICATION SITE PRURITUS 22
266 CHOROIDAL EFFUSION 22
267 DEVICE MECHANICAL ISSUE 22
268 HYPERAMMONAEMIA 22
269 LACTIC ACIDOSIS 22
270 MENTAL STATUS CHANGES 22
271 MYALGIA 22
272 NEUTROPENIA 22
273 POOR QUALITY SLEEP 22
274 RAYNAUD^S PHENOMENON 22
275 TOURETTE^S DISORDER 22
276 DISORIENTATION 21
277 DYSPEPSIA 21
278 EATING DISORDER 21
279 HEAD INJURY 21
280 INSURANCE ISSUE 21
281 OBESITY 21
282 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 21
283 STRESS CARDIOMYOPATHY 21
284 SWELLING FACE 21
285 THINKING ABNORMAL 21
286 ABNORMAL WEIGHT GAIN 20
287 APATHY 20
288 APPLICATION SITE IRRITATION 20
289 DISTRIBUTIVE SHOCK 20
290 DROOLING 20
291 DRUG EFFECT LESS THAN EXPECTED 20
292 DRUG TOLERANCE 20
293 DRUG WITHDRAWAL SYNDROME 20
294 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 20
295 EYE PAIN 20
296 HYPOTHERMIA 20
297 INJECTION SITE SWELLING 20
298 MYDRIASIS 20
299 PERIPHERAL COLDNESS 20
300 RESPIRATORY FAILURE 20
301 RHINORRHOEA 20
302 SWELLING 20
303 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 20
304 APPLICATION SITE PAIN 19
305 CARDIAC FAILURE 19
306 DIABETIC KETOACIDOSIS 19
307 DRUG ADMINISTERED AT INAPPROPRIATE SITE 19
308 DRUG LEVEL INCREASED 19
309 INJECTION SITE ERYTHEMA 19
310 INJECTION SITE REACTION 19
311 NEGATIVISM 19
312 NEPHROGENIC DIABETES INSIPIDUS 19
313 PSORIASIS 19
314 RECALLED PRODUCT ADMINISTERED 19
315 SKIN EXFOLIATION 19
316 VERTIGO 19
317 VIRAL INFECTION 19
318 ALANINE AMINOTRANSFERASE INCREASED 18
319 BALANCE DISORDER 18
320 DIPLOPIA 18
321 EXTRAPYRAMIDAL DISORDER 18
322 MACULAR DETACHMENT 18
323 NERVOUSNESS 18
324 RETCHING 18
325 SINUS TACHYCARDIA 18
326 SURGERY 18
327 ANAEMIA 17
328 CEREBRAL DISORDER 17
329 CEREBROVASCULAR ACCIDENT 17
330 DISSOCIATION 17
331 DISTRACTIBILITY 17
332 FEELING COLD 17
333 GASTROENTERITIS VIRAL 17
334 IMPAIRED QUALITY OF LIFE 17
335 LOGORRHOEA 17
336 POLLAKIURIA 17
337 PRIAPISM 17
338 PRODUCT ADMINISTRATION ERROR 17
339 RASH PRURITIC 17
340 SINUS ARRHYTHMIA 17
341 TINNITUS 17
342 WHITE BLOOD CELL COUNT INCREASED 17
343 BRAIN FOG 16
344 BRAIN OEDEMA 16
345 DEFIANT BEHAVIOUR 16
346 DEVICE USE ERROR 16
347 DRUG EFFECT INCREASED 16
348 DYSPHEMIA 16
349 FEELING JITTERY 16
350 HEART RATE ABNORMAL 16
351 HEPATIC ENZYME INCREASED 16
352 HOT FLUSH 16
353 HYPOPHAGIA 16
354 NEPHROLITHIASIS 16
355 PHARYNGITIS STREPTOCOCCAL 16
356 RENAL IMPAIRMENT 16
357 SKIN FISSURES 16
358 STAPHYLOCOCCAL INFECTION 16
359 CARDIAC DISORDER 15
360 CATARACT 15
361 CYANOSIS 15
362 DEVICE DIFFICULT TO USE 15
363 DYSGEUSIA 15
364 FLUID RETENTION 15
365 HYPOGLYCAEMIA 15
366 HYPOKALAEMIA 15
367 HYPOXIA 15
368 IMPAIRED GASTRIC EMPTYING 15
369 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 15
370 INFLUENZA LIKE ILLNESS 15
371 METABOLIC ACIDOSIS 15
372 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15
373 MUSCLE RIGIDITY 15
374 NERVOUS SYSTEM DISORDER 15
375 NEUROPATHY PERIPHERAL 15
376 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 15
377 RASH ERYTHEMATOUS 15
378 SENSORY DISTURBANCE 15
379 SINUS ARREST 15
380 SLEEP TERROR 15
381 SOMNAMBULISM 15
382 ATRIOVENTRICULAR BLOCK 14
383 BLINDNESS UNILATERAL 14
384 BLOOD CHOLESTEROL INCREASED 14
385 DIABETES MELLITUS 14
386 FLATULENCE 14
387 GROWTH RETARDATION 14
388 HOSTILITY 14
389 MUSCULOSKELETAL STIFFNESS 14
390 NEPHROGENIC ANAEMIA 14
391 OCULAR HYPERAEMIA 14
392 OEDEMA 14
393 OXYGEN SATURATION DECREASED 14
394 PANCREATITIS 14
395 PERSONALITY CHANGE 14
396 PRE-EXISTING CONDITION IMPROVED 14
397 PRODUCT DOSE OMISSION IN ERROR 14
398 PRODUCT USE COMPLAINT 14
399 RHABDOMYOLYSIS 14
400 SALIVARY HYPERSECRETION 14
401 SEDATION COMPLICATION 14
402 SEPSIS 14
403 SKIN DISCOLOURATION 14
404 SUICIDAL BEHAVIOUR 14
405 THERAPEUTIC RESPONSE CHANGED 14
406 ABNORMAL LOSS OF WEIGHT 13
407 ARTHRITIS 13
408 AUTONOMIC NERVOUS SYSTEM IMBALANCE 13
409 BLISTER 13
410 BLOOD TRIGLYCERIDES INCREASED 13
411 DRUG EFFECT INCOMPLETE 13
412 DYSPHONIA 13
413 DYSSTASIA 13
414 ERECTILE DYSFUNCTION 13
415 EXCESSIVE EYE BLINKING 13
416 EXTRA DOSE ADMINISTERED 13
417 EYE IRRITATION 13
418 EYE SWELLING 13
419 HYPERPROLACTINAEMIA 13
420 INFLAMMATION 13
421 NIGHT SWEATS 13
422 OBSTRUCTIVE AIRWAYS DISORDER 13
423 PHYSICAL ASSAULT 13
424 POOR QUALITY DEVICE USED 13
425 POST-TRAUMATIC STRESS DISORDER 13
426 PRODUCT PRESCRIBING ERROR 13
427 PRODUCT PRESCRIBING ISSUE 13
428 REBOUND EFFECT 13
429 ROAD TRAFFIC ACCIDENT 13
430 ANTICHOLINERGIC SYNDROME 12
431 ASPARTATE AMINOTRANSFERASE INCREASED 12
432 BRUGADA SYNDROME 12
433 CARDIAC FAILURE ACUTE 12
434 CIRCULATORY COLLAPSE 12
435 DRUG ABUSE 12
436 DRUG DISPENSING ERROR 12
437 DRY EYE 12
438 DYSURIA 12
439 ELECTROCARDIOGRAM T WAVE ABNORMAL 12
440 END STAGE RENAL DISEASE 12
441 EYE DISORDER 12
442 FEEDING DISORDER 12
443 GAIT INABILITY 12
444 HAEMATOCHEZIA 12
445 HERPES ZOSTER 12
446 HUNGER 12
447 HYPERGLYCAEMIA 12
448 ILL-DEFINED DISORDER 12
449 INJURY 12
450 LIP SWELLING 12
451 MOBILITY DECREASED 12
452 MYOCARDIAL INFARCTION 12
453 OROMANDIBULAR DYSTONIA 12
454 PRESCRIBED UNDERDOSE 12
455 PULMONARY EMBOLISM 12
456 RENAL DISORDER 12
457 SKIN HAEMORRHAGE 12
458 SLEEP APNOEA SYNDROME 12
459 SOCIAL PROBLEM 12
460 STARING 12
461 UPPER RESPIRATORY TRACT INFECTION 12
462 ANAPHYLACTIC REACTION 11
463 APPETITE DISORDER 11
464 ATAXIA 11
465 DERMATITIS 11
466 DISEASE PROGRESSION 11
467 DRUG LEVEL ABOVE THERAPEUTIC 11
468 FUNGAL INFECTION 11
469 HYPERTENSIVE URGENCY 11
470 IMMUNE THROMBOCYTOPENIC PURPURA 11
471 INFUSION SITE ERYTHEMA 11
472 INFUSION SITE PAIN 11
473 INSULIN RESISTANCE 11
474 LOWER RESPIRATORY TRACT INFECTION 11
475 MEDICATION RESIDUE PRESENT 11
476 NECK PAIN 11
477 PAIN OF SKIN 11
478 PRODUCT PREPARATION ISSUE 11
479 PRODUCT STORAGE ERROR 11
480 PRODUCT TASTE ABNORMAL 11
481 RASH MACULAR 11
482 RESPIRATORY ARREST 11
483 SELF INJURIOUS BEHAVIOUR 11
484 SEROUS RETINAL DETACHMENT 11
485 SEXUAL DYSFUNCTION 11
486 SHOCK 11
487 SOCIAL AVOIDANT BEHAVIOUR 11
488 STOMATITIS 11
489 SUSPECTED SUICIDE 11
490 VASOPLEGIA SYNDROME 11
491 ANAPHYLACTIC SHOCK 10
492 ANHEDONIA 10
493 CARDIO-RESPIRATORY ARREST 10
494 CARDIOGENIC SHOCK 10
495 DEAFNESS 10
496 DERMATITIS CONTACT 10
497 DEVICE MALFUNCTION 10
498 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 10
499 EOSINOPHILIC OESOPHAGITIS 10
500 EUPHORIC MOOD 10
501 FOETAL EXPOSURE DURING PREGNANCY 10
502 HAEMORRHAGE 10
503 HALLUCINATIONS, MIXED 10
504 HEPATIC FUNCTION ABNORMAL 10
505 HORNER^S SYNDROME 10
506 HYPERPHAGIA 10
507 INCONTINENCE 10
508 INJECTION SITE MASS 10
509 MIOSIS 10
510 ORTHOSTATIC INTOLERANCE 10
511 PLEURAL EFFUSION 10
512 PRODUCTIVE COUGH 10
513 PULSELESS ELECTRICAL ACTIVITY 10
514 RENAL INJURY 10
515 RIB FRACTURE 10
516 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 10
517 SLUGGISHNESS 10
518 STATUS EPILEPTICUS 10
519 TACHYPHRENIA 10
520 TRICHOTILLOMANIA 10
521 TROPONIN INCREASED 10
522 TYPE 2 DIABETES MELLITUS 10
523 ANGINA PECTORIS 9
524 APNOEA 9
525 ATRIAL FIBRILLATION 9
526 BLOOD LACTATE DEHYDROGENASE INCREASED 9
527 BLOOD PRESSURE FLUCTUATION 9
528 BLOOD PROLACTIN INCREASED 9
529 BODY MASS INDEX DECREASED 9
530 CARDIAC DYSFUNCTION 9
531 CARDIAC FAILURE CONGESTIVE 9
532 CHOKING 9
533 CHOLELITHIASIS 9
534 CLOSTRIDIUM DIFFICILE INFECTION 9
535 COLD SWEAT 9
536 CONCUSSION 9
537 COORDINATION ABNORMAL 9
538 DECREASED ACTIVITY 9
539 DEPRESSIVE SYMPTOM 9
540 DISABILITY 9
541 DISEASE RECURRENCE 9
542 DYSPHORIA 9
543 EYE MOVEMENT DISORDER 9
544 EYE PRURITUS 9
545 FORCED EXPIRATORY VOLUME DECREASED 9
546 FORMICATION 9
547 GALACTORRHOEA 9
548 GLYCOSYLATED HAEMOGLOBIN INCREASED 9
549 HYPERTENSIVE EMERGENCY 9
550 HYPOPROTEINAEMIA 9
551 IMPAIRED HEALING 9
552 INJECTION SITE URTICARIA 9
553 JOINT SWELLING 9
554 LEUKOCYTOSIS 9
555 LIVER DISORDER 9
556 MOUTH ULCERATION 9
557 MYOSITIS 9
558 PARALYSIS 9
559 PARKINSONISM 9
560 PETIT MAL EPILEPSY 9
561 PHARYNGEAL PARAESTHESIA 9
562 PHOTOPHOBIA 9
563 PLATELET COUNT DECREASED 9
564 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 9
565 SUBRETINAL FLUID 9
566 TEARFULNESS 9
567 THERAPEUTIC PRODUCT INEFFECTIVE 9
568 VENTRICULAR FIBRILLATION 9
569 VENTRICULAR TACHYCARDIA 9
570 WEIGHT GAIN POOR 9
571 WRONG PRODUCT ADMINISTERED 9
572 ANION GAP 8
573 APHASIA 8
574 ARTHROPATHY 8
575 ASPIRATION 8
576 ATRIOVENTRICULAR BLOCK COMPLETE 8
577 ATRIOVENTRICULAR BLOCK FIRST DEGREE 8
578 AUTISM 8
579 BIPOLAR I DISORDER 8
580 BLOOD CREATININE DECREASED 8
581 BLOOD GLUCOSE DECREASED 8
582 BLOOD UREA INCREASED 8
583 BRUXISM 8
584 BUNDLE BRANCH BLOCK RIGHT 8
585 BURNING SENSATION 8
586 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8
587 COELIAC DISEASE 8
588 CYSTIC FIBROSIS 8
589 DERMATILLOMANIA 8
590 DEVICE DELIVERY SYSTEM ISSUE 8
591 DRUG RESISTANCE 8
592 EXPIRED PRODUCT ADMINISTERED 8
593 EXPOSURE DURING PREGNANCY 8
594 GRAND MAL CONVULSION 8
595 GRANDIOSITY 8
596 HAEMOPTYSIS 8
597 HAIR GROWTH ABNORMAL 8
598 HYPERTENSIVE CRISIS 8
599 HYPERVENTILATION 8
600 HYPOMANIA 8
601 IMPULSE-CONTROL DISORDER 8
602 INCORRECT DOSE ADMINISTERED BY DEVICE 8
603 INFUSION SITE PRURITUS 8
604 INJECTION SITE HAEMORRHAGE 8
605 INTERMITTENT EXPLOSIVE DISORDER 8
606 IRRITABLE BOWEL SYNDROME 8
607 LIMB DISCOMFORT 8
608 NEGATIVE THOUGHTS 8
609 PAIN IN JAW 8
610 POISONING 8
611 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 8
612 PRODUCT FORMULATION ISSUE 8
613 PRODUCT RESIDUE PRESENT 8
614 PRODUCT SUPPLY ISSUE 8
615 PRURITUS GENERALISED 8
616 PSYCHIATRIC SYMPTOM 8
617 RESPIRATORY DISORDER 8
618 SKIN BURNING SENSATION 8
619 SUBSTANCE ABUSE 8
620 TRANSCRIPTION MEDICATION ERROR 8
621 TRANSIENT ISCHAEMIC ATTACK 8
622 TRISMUS 8
623 UPPER AIRWAY OBSTRUCTION 8
624 UPPER LIMB FRACTURE 8
625 WEIGHT FLUCTUATION 8
626 WITHDRAWAL HYPERTENSION 8
627 ABASIA 7
628 ABNORMAL DREAMS 7
629 ACTIVITIES OF DAILY LIVING IMPAIRED 7
630 ACUTE RESPIRATORY DISTRESS SYNDROME 7
631 ANGIOEDEMA 7
632 ANXIETY DISORDER 7
633 APPLICATION SITE RASH 7
634 ATRIOVENTRICULAR DISSOCIATION 7
635 BLINDNESS 7
636 BLOOD POTASSIUM DECREASED 7
637 BRAIN INJURY 7
638 CARDIOTOXICITY 7
639 CYSTITIS 7
640 DECREASED INTEREST 7
641 DEVICE ADHESION ISSUE 7
642 DEVICE EXPULSION 7
643 DEVICE INFORMATION OUTPUT ISSUE 7
644 DEVICE PHYSICAL PROPERTY ISSUE 7
645 DIABETES MELLITUS INADEQUATE CONTROL 7
646 DISRUPTIVE MOOD DYSREGULATION DISORDER 7
647 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7
648 DRUG LEVEL DECREASED 7
649 DRUG TITRATION ERROR 7
650 ELECTROCARDIOGRAM ABNORMAL 7
651 ELECTROCARDIOGRAM T WAVE PEAKED 7
652 ENERGY INCREASED 7
653 FOOD ALLERGY 7
654 GRIMACING 7
655 HAEMOGLOBIN DECREASED 7
656 HYPOACUSIS 7
657 HYPOTHYROIDISM 7
658 INFUSION SITE SWELLING 7
659 INHIBITORY DRUG INTERACTION 7
660 INJECTION SITE PRURITUS 7
661 INTESTINAL OBSTRUCTION 7
662 JUDGEMENT IMPAIRED 7
663 LEARNING DISORDER 7
664 LIMB INJURY 7
665 LISTLESS 7
666 LONG QT SYNDROME 7
667 LOWER LIMB FRACTURE 7
668 LUNG DISORDER 7
669 LYMPHADENOPATHY 7
670 MAJOR DEPRESSION 7
671 MATERNAL EXPOSURE DURING PREGNANCY 7
672 NEURALGIA 7
673 NEUROTOXICITY 7
674 OVERWEIGHT 7
675 PANIC REACTION 7
676 PARKINSON^S DISEASE 7
677 PERSONALITY DISORDER 7
678 PNEUMONIA ASPIRATION 7
679 PRODUCT COMPLAINT 7
680 PRODUCT DISTRIBUTION ISSUE 7
681 PSYCHOTIC SYMPTOM 7
682 RASH PUSTULAR 7
683 RECTAL HAEMORRHAGE 7
684 RESTLESS LEGS SYNDROME 7
685 SCRATCH 7
686 SEPTIC SHOCK 7
687 SKIN IRRITATION 7
688 SKIN LACERATION 7
689 SLEEP DEFICIT 7
690 SLEEP TALKING 7
691 SNORING 7
692 STEREOTYPY 7
693 SWOLLEN TONGUE 7
694 TEMPERATURE INTOLERANCE 7
695 THERAPEUTIC PRODUCT EFFECT VARIABLE 7
696 WHEEZING 7
697 WRONG DOSE 7
698 ACTIVATION SYNDROME 6
699 BICYTOPENIA 6
700 BLEPHAROSPASM 6
701 BLOOD SODIUM DECREASED 6
702 CEREBRAL HAEMORRHAGE 6
703 CEREBRAL ISCHAEMIA 6
704 CHOROIDAL DETACHMENT 6
705 COMPLICATION ASSOCIATED WITH DEVICE 6
706 CRANIOCEREBRAL INJURY 6
707 DEEP VEIN THROMBOSIS 6
708 DEVICE DISLOCATION 6
709 DISINHIBITION 6
710 DRUG EFFECT VARIABLE 6
711 DRUG-GENETIC INTERACTION 6
712 EAR PAIN 6
713 FLAT AFFECT 6
714 FOOT FRACTURE 6
715 FORCED EXPIRATORY VOLUME ABNORMAL 6
716 GLOMERULAR FILTRATION RATE DECREASED 6
717 HEAD BANGING 6
718 HEAD DISCOMFORT 6
719 HYPERACUSIS 6
720 IMPAIRED WORK ABILITY 6
721 INCORRECT PRODUCT ADMINISTRATION DURATION 6
722 INFUSION RELATED REACTION 6
723 INJECTION SITE BRUISING 6
724 INTRUSIVE THOUGHTS 6
725 JOINT INJURY 6
726 LIQUID PRODUCT PHYSICAL ISSUE 6
727 LIVER FUNCTION TEST ABNORMAL 6
728 LOCALISED INFECTION 6
729 MAST CELL ACTIVATION SYNDROME 6
730 MENSTRUATION IRREGULAR 6
731 MYOCLONUS 6
732 NEEDLE ISSUE 6
733 PANCREATITIS ACUTE 6
734 PARADOXICAL DRUG REACTION 6
735 POOR VENOUS ACCESS 6
736 PREGNANCY 6
737 PRODUCT PACKAGING ISSUE 6
738 PRODUCT PACKAGING QUANTITY ISSUE 6
739 RASH GENERALISED 6
740 RASH PAPULAR 6
741 RENAL FAILURE ACUTE 6
742 RENAL TUBULAR NECROSIS 6
743 RESPIRATORY ACIDOSIS 6
744 SCAR 6
745 SCHIZOPHRENIA 6
746 SCOLIOSIS 6
747 SEASONAL ALLERGY 6
748 SELECTIVE MUTISM 6
749 SELF ESTEEM DECREASED 6
750 SENSITIVITY TO WEATHER CHANGE 6
751 STARVATION 6
752 STEVENS-JOHNSON SYNDROME 6
753 STREPTOCOCCAL INFECTION 6
754 SUPRAVENTRICULAR EXTRASYSTOLES 6
755 THROMBOCYTOPENIA 6
756 THROMBOSIS 6
757 TORTICOLLIS 6
758 VENTRICULAR EXTRASYSTOLES 6
759 VISUAL FIELD DEFECT 6
760 ABORTION SPONTANEOUS 5
761 ADVERSE REACTION 5
762 AMENORRHOEA 5
763 BACTERIAL INFECTION 5
764 BENIGN PROSTATIC HYPERPLASIA 5
765 BLOOD ALKALINE PHOSPHATASE INCREASED 5
766 BLOOD PRESSURE ABNORMAL 5
767 BLOOD PRESSURE SYSTOLIC DECREASED 5
768 BLOOD TESTOSTERONE DECREASED 5
769 BLOOD URIC ACID INCREASED 5
770 BODY TEMPERATURE DECREASED 5
771 CARDIAC ANEURYSM 5
772 CARDIOVASCULAR SYMPTOM 5
773 CELLULITIS 5
774 CEREBRAL INFARCTION 5
775 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5
776 COLITIS ULCERATIVE 5
777 CONJUNCTIVITIS 5
778 DARK CIRCLES UNDER EYES 5
779 DEVELOPMENTAL DELAY 5
780 DEVICE DEFECTIVE 5
781 DRUG EFFECT DELAYED 5
782 DRY THROAT 5
783 DYSPNOEA EXERTIONAL 5
784 ECONOMIC PROBLEM 5
785 ELECTROCARDIOGRAM QT SHORTENED 5
786 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 5
787 ELECTROENCEPHALOGRAM ABNORMAL 5
788 EXERCISE TOLERANCE DECREASED 5
789 FEELING DRUNK 5
790 GASTRITIS 5
791 GAZE PALSY 5
792 GLAUCOMA 5
793 GRANULOCYTOPENIA 5
794 GROWTH FAILURE 5
795 HAEMATEMESIS 5
796 HALLUCINATION, TACTILE 5
797 HEPATIC FAILURE 5
798 HEREDITARY ANGIOEDEMA 5
799 HYPERTENSIVE ENCEPHALOPATHY 5
800 HYPERTONIC BLADDER 5
801 HYPOKINESIA 5
802 HYPONATRAEMIA 5
803 HYPORESPONSIVE TO STIMULI 5
804 HYPOTONIA 5
805 HYSTERECTOMY 5
806 ILEUS 5
807 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 5
808 INAPPROPRIATE AFFECT 5
809 INCOHERENT 5
810 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 5
811 INFUSION SITE DISCHARGE 5
812 INFUSION SITE HAEMORRHAGE 5
813 INFUSION SITE REACTION 5
814 INJECTION SITE VESICLES 5
815 LEFT VENTRICULAR DYSFUNCTION 5
816 LEFT VENTRICULAR HYPERTROPHY 5
817 LIBIDO DECREASED 5
818 LOSS OF LIBIDO 5
819 MALNUTRITION 5
820 MENSTRUAL DISORDER 5
821 MUSCLE TIGHTNESS 5
822 MUSCULOSKELETAL DISCOMFORT 5
823 MUSCULOSKELETAL PAIN 5
824 NEOPLASM MALIGNANT 5
825 NO THERAPEUTIC RESPONSE 5
826 NONSPECIFIC REACTION 5
827 ORAL HERPES 5
828 ORAL PAIN 5
829 OSTEOARTHRITIS 5
830 PANCYTOPENIA 5
831 PERSECUTORY DELUSION 5
832 PNEUMOTHORAX 5
833 POISONING DELIBERATE 5
834 POLYDIPSIA 5
835 PROCEDURAL PAIN 5
836 PRODUCT CONTAMINATION 5
837 PRODUCT PREPARATION ERROR 5
838 PSORIATIC ARTHROPATHY 5
839 PULMONARY HAEMORRHAGE 5
840 REACTION TO EXCIPIENT 5
841 REBOUND ACID HYPERSECRETION 5
842 RESPIRATORY DISTRESS 5
843 RESPIRATORY RATE DECREASED 5
844 RESPIRATORY RATE INCREASED 5
845 RESPIRATORY TRACT INFECTION 5
846 RESTLESS LEG AUGMENTATION SYNDROME 5
847 RHEUMATOID ARTHRITIS 5
848 RHINOVIRUS INFECTION 5
849 SELECTIVE EATING DISORDER 5
850 SINUS CONGESTION 5
851 SINUS DISORDER 5
852 SKIN DISORDER 5
853 SKIN ULCER 5
854 SNEEZING 5
855 SOCIAL ANXIETY DISORDER 5
856 THROAT IRRITATION 5
857 TOXIC EPIDERMAL NECROLYSIS 5
858 TRANSAMINASES INCREASED 5
859 TRANSPLANT REJECTION 5
860 TROPONIN I INCREASED 5
861 TUBULOINTERSTITIAL NEPHRITIS 5
862 TYPE 1 DIABETES MELLITUS 5
863 ABULIA 4
864 ACIDOSIS 4
865 ACUTE RESPIRATORY FAILURE 4
866 AGEUSIA 4
867 ANAL INCONTINENCE 4
868 ANTICHOLINERGIC EFFECT 4
869 APPLICATION SITE SCAB 4
870 AREFLEXIA 4
871 ARTERIOSPASM CORONARY 4
872 ARTHROPOD BITE 4
873 ATRIOVENTRICULAR BLOCK SECOND DEGREE 4
874 BACK DISORDER 4
875 BLOOD BILIRUBIN INCREASED 4
876 BLOOD IMMUNOGLOBULIN E INCREASED 4
877 BLOOD LACTIC ACID INCREASED 4
878 BLOOD POTASSIUM INCREASED 4
879 BLOOD THYROID STIMULATING HORMONE DECREASED 4
880 BODY HEIGHT DECREASED 4
881 BODY TEMPERATURE INCREASED 4
882 CARBON DIOXIDE INCREASED 4
883 CARDIAC FLUTTER 4
884 CARDIOMEGALY 4
885 CARPAL TUNNEL SYNDROME 4
886 CATHETER SITE INFECTION 4
887 CHANGE IN SEIZURE PRESENTATION 4
888 CHANGE IN SUSTAINED ATTENTION 4
889 CHAPPED LIPS 4
890 CHOLECYSTECTOMY 4
891 CHROMATURIA 4
892 COMPLICATION OF DEVICE INSERTION 4
893 CONDUCT DISORDER 4
894 CONTRAINDICATED PRODUCT ADMINISTERED 4
895 CONTRAINDICATED PRODUCT PRESCRIBED 4
896 CONVERSION DISORDER 4
897 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 4
898 DEVICE MATERIAL ISSUE 4
899 DEVICE OCCLUSION 4
900 DRUG DELIVERY SYSTEM ISSUE 4
901 DRUG SCREEN FALSE POSITIVE 4
902 DRUG TOLERANCE DECREASED 4
903 DRUG WITHDRAWAL CONVULSIONS 4
904 DRUG WITHDRAWAL SYNDROME NEONATAL 4
905 ELECTRIC SHOCK SENSATION 4
906 ELECTROCARDIOGRAM T WAVE AMPLITUDE INCREASED 4
907 EXPIRED DEVICE USED 4
908 EXPIRED DRUG ADMINISTERED 4
909 EXPOSURE VIA SKIN CONTACT 4
910 FACE OEDEMA 4
911 FEBRILE NEUTROPENIA 4
912 FIBROMYALGIA 4
913 FLUID INTAKE REDUCED 4
914 FOETAL ALCOHOL SYNDROME 4
915 FOOT DEFORMITY 4
916 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 4
917 FREQUENT BOWEL MOVEMENTS 4
918 FRUSTRATION 4
919 GAMING DISORDER 4
920 GASTRIC DISORDER 4
921 GASTROINTESTINAL PAIN 4
922 GENERALISED OEDEMA 4
923 GOUT 4
924 HAEMATOCRIT DECREASED 4
925 HAEMATOMA 4
926 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4
927 HAEMORRHOIDAL HAEMORRHAGE 4
928 HEART RATE IRREGULAR 4
929 HEPATITIS ACUTE 4
930 HYPERKALAEMIA 4
931 HYPERLIPIDAEMIA 4
932 HYPERTRICHOSIS 4
933 HYPOAESTHESIA ORAL 4
934 IMMUNODEFICIENCY 4
935 IMPAIRED DRIVING ABILITY 4
936 INCREASED TENDENCY TO BRUISE 4
937 INJECTION SITE RASH 4
938 INTERVERTEBRAL DISC PROTRUSION 4
939 JAUNDICE 4
940 JOINT DISLOCATION 4
941 KIDNEY INFECTION 4
942 LIGAMENT SPRAIN 4
943 LOW BIRTH WEIGHT BABY 4
944 MANUFACTURING MATERIALS ISSUE 4
945 METABOLIC DISORDER 4
946 MOTOR DYSFUNCTION 4
947 MUCOUS STOOLS 4
948 NARCOLEPSY 4
949 NEAR DEATH EXPERIENCE 4
950 NEUTROPHIL COUNT DECREASED 4
951 NYSTAGMUS 4
952 ORAL DISORDER 4
953 OROPHARYNGEAL DISCOMFORT 4
954 PARAESTHESIA ORAL 4
955 PATIENT UNCOOPERATIVE 4
956 PERIODIC LIMB MOVEMENT DISORDER 4
957 PHOTOSENSITIVITY REACTION 4
958 POOR SCHOOL ATTENDANCE 4
959 POSTURING 4
960 PRODUCT COMMUNICATION ISSUE 4
961 PRODUCT CONTAINER ISSUE 4
962 PRODUCT DISPENSING ISSUE 4
963 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4
964 PROTRUSION TONGUE 4
965 PSEUDOMONAS INFECTION 4
966 PULMONARY CONGESTION 4
967 PULSE ABSENT 4
968 RENAL CELL CARCINOMA 4
969 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4
970 SARS-COV-2 TEST POSITIVE 4
971 SCAB 4
972 SENSITIVE SKIN 4
973 SICKLE CELL ANAEMIA WITH CRISIS 4
974 SKIN STRIAE 4
975 SPINAL OPERATION 4
976 STAPHYLOCOCCAL BACTERAEMIA 4
977 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 4
978 SUDDEN HEARING LOSS 4
979 SUSPECTED COUNTERFEIT PRODUCT 4
980 THROAT TIGHTNESS 4
981 TONIC CONVULSION 4
982 TOOTHACHE 4
983 TORSADE DE POINTES 4
984 VAGINAL HAEMORRHAGE 4
985 VENTRICULAR DYSKINESIA 4
986 VERBAL ABUSE 4
987 VIOLENCE-RELATED SYMPTOM 4
988 VITAMIN D DECREASED 4
989 WOLFF-PARKINSON-WHITE SYNDROME 4
990 WRONG DRUG ADMINISTERED 4
991 ZINC DEFICIENCY 4
992 ABDOMINAL PAIN LOWER 3
993 ABNORMAL UTERINE BLEEDING 3
994 ACCIDENTAL EXPOSURE 3
995 ACUTE PSYCHOSIS 3
996 ADHESIVE TAPE USE 3
997 ADRENAL INSUFFICIENCY 3
998 AGORAPHOBIA 3
999 AKINESIA 3